Clinical Trial Update: The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on the effects of resveratrol supplementation on biochemical factors and hepatic fibrosis in patients with nonalcoholic steat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: Dr Azita Hekmatdoost | Conditions: Non Alcoholic Fatty Liver | Phase 2, Phase 3 | Status: COMPLETED